• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Mark Egerton - Articles and news items


Sunesis Pharmaceuticals selects Quotient Clinical’s real-time adaptive manufacturing to support its vosaroxin clinical mass balance/ADME program

Supplier news / 21 January 2015 / kdm communications

Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)…

Quotient Clinical

Quotient Clinical extends its Translational Pharmaceutics™ platform into cancer drug development

Supplier news / 7 May 2014 / kdm communications

Quotient Clinical has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development…

Quotient Clinical

Quotient Clinical celebrates its 50th RapidFACT™ program

Supplier news / 7 February 2014 / kdm communications

Quotient Clinical has commenced its 50th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the development of this service…

Quotient Clinical

Bridgepoint Development Capital to acquire Quotient Clinical

Supplier news / 11 December 2013 / KDM Communications

Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum…


Quotient Clinical announces major expansion of its GMP manufacturing and formulation development capacity

News, Supplier news / 3 March 2011 / The Scott Partnership

To accommodate demand for its RapidFACT Service…

Quotient Clinical and Bend Research Announce Collaboration To Accelerate Advancement of New Medicines

News, Supplier news / 10 November 2010 / The Scott Partnership

Speeding the advance of compounds to clinical trials and expanding options for drug delivery…

Quotient Bioresearch Highlight Integrated Early Stage Drug Development Platforms

News, Supplier news / 12 October 2010 / The Scott Partnership

Quotient Bioresearch, will be highlighting integrated early stage drug development platforms at FIP Pharmaceutical Sciences World Congress…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +